Anti-Reflux Devices Market Size, Share & COVID-19 Impact Analysis-Global-2022-2028-MedCore
The total global anti-reflux device market is growing at a rate of almost 23%, which will take the 2021 market value of $114 million up to $486 million by 2028.
The full report suite on the global market for anti-reflux devices includes a variety of procedure techniques to treat GERD, such as transoral incisionless fundoplication (TIF), transesophageal radiofrequency and the LINX® technique.
MARKET REPORT DATA TYPES INCLUDED
Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2028, and Historical Data to 2018
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
PROCEDURE NUMBERS
Historically, the anti-reflux device implementation procedure market has been limited by large untreated populations and competition from medicinal treatments. However, surgeons have recently been promoting this procedure to individuals as a way to market their practice and diversify their surgical offerings. With increasing popularity, the procedure is expected to experience strong growth rates.
GLOBAL ANTI-REFLUX DEVICE MARKET TRENDS
In 202, the global market value for the anti=reflux device market decreased due to the mass cancelation of elective surgical procedures during the COVID-19 pandemic. As recovery continues throughout 2021 and 2022, strong growth should be seen over the forecast period.
GLOBAL ANTI-REFLUX DEVICE MARKET SHARE INSIGHTS
Overall, within the global anti-reflux device market there are three dominant competitors: Johnson & Johnson, EndoGastric Solutions, and Restech. In 2021, the leading competitor in the anti-reflux device market was Johnson & Johnson. Johnson & Johnson offers the LINX® reflux management system. This device is essentially a flexible band of interlinked titanium beads with magnetic cores that is wrapped around the lower part of the esophagus.
MARKET SEGMENTATION SUMMARY
Global Anti-Reflux Device Market
RESEARCH SCOPE SUMMARY
Regions – North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year – 2021
Forecast – 2022-2028
Historical Data – 2018-2021
Quantitative Coverage – Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage – COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources – Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
WHY CHOOSE iDATA?
Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail - It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Work with us, and you’ll work with seasoned professionals – vigilant of deadlines, and committed to providing the most up-to-date, accurate medical device market research.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook